Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/16/2026

Depression and Anxiety Management

Screening and Assessment

  • The PHQ-9 uses severity categories based on total scores ranging from 0-27 to assess depression, with scores of 0-4 indicating minimal symptoms, 5-9 indicating mild symptoms, 10-14 indicating moderate symptoms, 15-19 indicating moderately severe symptoms, and 20-27 indicating severe symptoms 1, 2
  • The GAD-7 uses severity categories based on total scores ranging from 0-21 to assess anxiety, with scores of 0-4 indicating minimal symptoms, 5-9 indicating mild symptoms, 10-14 indicating moderate symptoms, and 15-21 indicating severe symptoms 1, 2
  • Regardless of total score, immediately assess item 9 of the PHQ-9 regarding thoughts of self-harm or being better off dead, and refer for emergency psychiatric evaluation if any frequency is endorsed 1, 2, 3
  • Additional red flags requiring immediate referral include risk of harm to others, severe agitation, psychosis, or confusion/delirium 1, 2

Management Algorithm

  • For minimal symptoms (PHQ-9: 0-4, GAD-7: 0-4), no formal intervention is required, but provide patient education and verify adequate coping skills and social support systems 4, 1, 3
  • For mild symptoms (PHQ-9: 5-9, GAD-7: 5-9), provide supportive care with scheduled monitoring, and educate the patient about depression/anxiety and normalize their experience while validating concerns 4, 3
  • For moderate symptoms (PHQ-9: 10-14, GAD-7: 10-14), consider low-intensity interventions and consultation with mental health professionals for diagnostic confirmation, and conduct further diagnostic assessment to identify the nature and extent of symptoms 4, 5, 1
  • For moderate to severe/severe symptoms (PHQ-9: 15-27, GAD-7: 15-21), immediate referral to psychology and/or psychiatry for formal diagnosis and high-intensity treatment is mandatory, and symptoms at this level interfere moderately to markedly with functioning 4, 1, 6

Special Considerations

  • The PHQ-9 has strong diagnostic validity with 89.5% sensitivity and 77.5% specificity at a cut-off score of 11 for detecting major depressive disorder 6
  • Patients with GAD may not present with obvious anxiety symptoms, and the pathognomonic GAD symptom (multiple excessive worries) may present as "concerns" or "fears" 7
  • Consider possible comorbid anxiety diagnoses such as panic disorder, social phobia, or PTSD 7

Evidence‑Based Discharge Criteria and Follow‑up for Depression and Anxiety

Symptom Severity Thresholds

  • A Generalized Anxiety Disorder‑7 (GAD‑7) score ≤ 9 reflects mild or minimal anxiety symptoms and falls below the moderate threshold that would necessitate ongoing specialty mental‑health care【8】【9】.

Safety Planning

  • Completion of a written safety plan provides a structured crisis‑response strategy for patients after discharge【10】.
  • Ensuring patients have immediate access to crisis resources (e.g., hotlines, emergency services) guarantees rapid intervention if symptoms worsen【10】.

Follow‑up and Continuity of Care

  • Patients should have a follow‑up appointment with primary care or a continuing mental‑health provider within 1–2 weeks of discharge to verify ongoing stability【10】.
  • This rapid follow‑up aligns with the 48‑hour recommendation used for high‑risk medical discharges and helps prevent clinical deterioration【10】.
  • Scheduling follow‑up visits before discharge is essential because gaps in care are associated with higher rehospitalisation rates and adverse outcomes【10】.

Relapse Prevention and Functional Impairment

  • Education on early warning signs—such as the return of excessive worry, sleep disturbance, irritability, or concentration difficulties—helps patients and clinicians detect relapse promptly【8】.
  • Persistent functional impairment, even when symptom scores remain in the mild range, should trigger referral back to specialized mental‑health services【8】.

Comorbid Condition Screening

  • Prior to discharge, clinicians should screen for comorbid conditions (e.g., substance‑use disorders) and arrange connection to appropriate behavioral‑health services when needed【10】.

REFERENCES

3

Management of Mild Depressive Symptoms [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Significance of PHQ-9 Score for Depression [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Treatment for Moderate to Severe Depression [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025